SCHEMBL1675201

SCHEMBL1675201

CN(c1nccs1)c1ncnc2ccc(-c3ccc(CO)o3)cc12

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 15/20 0.67
CLK1 P49759 8/20 0.67
DYRK1A Q13627 7/20 0.67
CLK2 P49760 7/20 0.67
DYRK1B Q9Y463 7/20 0.67
CLK3 P49761 2/20 0.44
EGFR P00533 2/20 0.43
PI4KB Q9UBF8 1/20 0.43
CDK2 P24941 2/20 0.41
CYP1A2 P05177 6/20 0.39
CYP3A4 P08684 6/20 0.39
MAPK1 P28482 4/20 0.39
LMNA P02545 4/20 0.39
ALDH1A1 P00352 3/20 0.39
MEN1 O00255 1/20 0.39
TP53 P04637 1/20 0.39
CASP1 P29466 1/20 0.39
CASP7 P55210 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1675083 0.85 CLK4 (0.61) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675047 0.84 CLK4 (0.63) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675105 0.84 CLK4 (0.48) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675224 0.81 CLK4 (0.64) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675295 0.80 CLK4 (0.55) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675078 0.80 CLK4 (1.00) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675230 0.80 CLK4 (0.60) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675179 0.77 CLK4 (0.52) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675160 0.76 CLK4 (0.71) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675203 0.74 CLK4 (0.73) CLK4CLK1DYRK1ACLK2DYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed